뇌졸중의 바이오마커

키워드

참고문헌 (53)

1. Chimowitz MI, "Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis", N Engl J Med, 352, pp.1305~1316 (2005)
2. Diener HC, "Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (match): Randomised, double-blind, placebo-controlled trial", Lancet, 364, pp.331~337 (2004)
3. Bhatt DL, "Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events", N Engl J Med, 354, pp.1706~1717 (2006)
4. Hacke W, "Intravenous desmoteplase in patients with acute ischaemic stroke selected by mri perfusion-diffusion weighted imaging or perfusion ct (dias-2): A prospective, randomised, double-blind, placebo-controlled study", Lancet Neurol, 8, pp.141~150 (2009)
5. Davis SM, "Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (epithet): A placebo-controlled randomised trial", Lancet Neurol, 7, pp.299~309 (2008)
6. Shuaib A, "Nxy-059 for the treatment of acute ischemic stroke", N Engl J Med, 357, pp.562~571 (2007)
7. Gorelick PB, "Stroke prevention therapy beyond antithrombotics: Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: An invited review", Stroke, 33, pp.862~875 (2002)
8. 방오영, "Are Stroke Biomarkers Seeing Brain Vessels in Patients With Ischemic Stroke? A C-Reactive Protein and Homocysteine Study", STROKE, 42(5), pp.1464~1468, LIPPINCOTT WILLIAMS WILKINS
9. Castellanos M, "Serum cellular fi bronectin and matrix metalloproteinase- 9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confi rmatory study", Stroke, 38, pp.1855~1859 (2007)
10. Bang OY, "Infl ammatory markers, rather than conventional risk factors, are different between carotid and mca atherosclerosis", J Neurol Neurosurg Psychiatry, 76, pp.1128~1134 (2005)
11. Hamedani AG, "Meta-analysis of factor v leiden and ischemic stroke in young adults: The importance of case ascertainment", Stroke, 41, pp.1599~1603 (2010)
12. Tohgi H, "Activated coagulation", fi brinolysis system and platelet function in acute thrombotic stroke patients with increased c-reactive protein levels, 2000, pp.100, 373~379
13. Van Der Meer IM, "C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: The rotterdam study", Stroke, 33, pp.2750~2755 (2002)
14. Yip HK, "Levels and value of platelet activity in patients with severe internal carotid artery stenosis", Neurology, 66, pp.804~808 (2006)
15. Barseghian A, "Adiponectin and vulnerable atherosclerotic plaques", J Am Coll Cardiol, 57, pp.761~770 (2011)
16. Zacho J, "Genetically elevated c-reactive protein and ischemic vascular disease", N Engl J Med, 359, pp.1897~1908 (2008)
17. Tosetto A, "Association of plasma fi brinogen, c-reactive protein and g-455>a polymorphism with early atherosclerosis in the vita project cohort", Thromb Haemost, 105, pp.329~335 (2011)
18. Yamada Y, "Genetic factors for ischemic and hemorrhagic stroke in japanese individuals", Stroke, 39, pp.2211~2218 (2008)
19. Dong C, "Genomewide linkage and peakwide association analyses of carotid plaque in caribbean hispanics", Stroke, 41, pp.2750~2756 (2010)
20. Kuriyama N, "Evaluation of factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction", Clin Appl Thromb Hemost, 16, pp.26~32 (2010)
21. Jung KH, "Circulating endothelial microparticles as a marker of cerebrovascular disease", Ann Neurol, 66, pp.191~199 (2009)
22. Arenillas JF, "Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinfl ammatory state and impaired fibrinolysis", Stroke, 39, pp.1456~1463 (2008)
23. Arenillas JF, "Angiogenesis in symptomatic intracranial atherosclerosis: Predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence", Stroke, 36, pp.92~97 (2005)
24. Yamada Y, "Association of genetic variants with atherothrombotic cerebral infarction in japanese individuals with metabolic syndrome", Int J Mol Med, 21, pp.801~808 (2008)
25. Montaner J, "Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers", Stroke, 39, pp.2280~2287 (2008)
26. Kataoka S, "Activation of thrombosis and fi brinolysis following brain infarction", J Neurol Sci, 181, pp.82~88 (2000)
27. Conway DS, "Prognostic value of plasma von willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation", Circulation, 107, pp.3141~3145 (2003)
28. Ferro D, "Soluble cd40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fi brillation", Arterioscler Thromb Vasc Biol, 27, pp.2763~2768 (2007)
29. Gretarsdottir S, "Risk variants for atrial fi brillation on chromosome 4q25 associate with ischemic stroke", Ann Neurol, 64, pp.402~409 (2008)
30. Choudhury A, "Elevated platelet microparticle levels in nonvalvular atrial fi brillation: Relationship to p-selectin and antithrombotic therapy", Chest, 131, pp.809~815 (2007)
31. Fornage M, "Biomarkers of inflammation and mridefined small vessel disease of the brain: The cardiovascular health study", Stroke, 39, pp.1952~1959 (2008)
32. Kubo M, "A nonsynonymous snp in prkch (protein kinase c eta) increases the risk of cerebral infarction", Nat Genet, 39, pp.212~217 (2007)
33. Bevan S, "Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: A replication study in two independent populations", Stroke, 39, pp.1109~1114 (2008)
34. Di Tullio MR, "Aortic atherosclerosis, hypercoagulability, and stroke the apris (aortic plaque and risk of ischemic stroke) study", J Am Coll Cardiol, 52, pp.855~861 (2008)
35. Hron G, "Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer", Thromb Haemost, 97, pp.119~123 (2007)
36. Lackner P, "Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage", Stroke, 41, pp.2353~2357 (2010)
37. Lynch JR, "Novel diagnostic test for acute stroke", Stroke, 35, pp.57~63 (2004)
38. Ridker PM, "Infl ammation, aspirin, and the risk of cardiovascular disease in apparently healthy men", N Engl J Med, 336, pp.973~979 (1997)
39. Ridker PM, "Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein", N Engl J Med, 359, pp.2195~2207 (2008)
40. Nordestgaard BG, "Does elevated c-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere", Curr Opin Lipidol, 20, pp.393~401 (2009)
41. Whiteley W, "Association of circulating infl ammatory markers with recurrent vascular events after stroke: A prospective cohort study", Stroke, 42, pp.10~16 (2011)
42. Hemingway H, "Evaluating the quality of research into a single prognostic biomarker: A systematic review and meta-analysis of 83 studies of c-reactive protein in stable coronary artery disease", PLoS Med, 7, pp.e1000286~ (2010)
43. Hankey GJ, "Potential new risk factors for ischemic stroke: What is their potential", Stroke, 37, pp.2181~2188 (2006)
44. "Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): A case-control study", Lancet, 376, pp.112~123 (2010)
45. Wang TJ, "Multiple biomarkers for the prediction of first major cardiovascular events and death", N Engl J Med, 355, pp.2631~2639 (2006)
46. Nambi V, "Lipoprotein-associated phospholipase a2 and highsensitivity c-reactive protein improve the stratifi cation of ischemic stroke risk in the atherosclerosis risk in communities (aric) study", Stroke, 40, pp.376~381 (2009)
47. Dichgans M, "Genetics of ischaemic stroke", Lancet Neurol, 6, pp.149~161 (2007)
48. Hegele RA, "Update on the genetics of stroke and cerebrovascular disease 2007", Stroke, 39, pp.252~254 (2008)
49. Meschia JF, "Advances in genetics 2010", Stroke, 42, pp.285~287 (2011)
50. Lanktree MB, "Advances in genomic analysis of stroke: What have we learned and where are we headed", Stroke, 41, pp.825~832 (2010)
51. Ikram MA, "Genomewide association studies of stroke", N Engl J Med, 360, pp.1718~1728 (2009)
52. Leroyer AS, "Microparticles from ischemic muscle promotes postnatal vasculogenesis", Circulation, 119, pp.2808~2817 (2009)
53. Nozaki T, "Signifi cance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratifi cation for cardiovascular events in patients at high risk for coronary heart disease", J Am Coll Cardiol, 54, pp.601~608 (2009)

관련 논문AI추천